Key result
POCUS rapidly identifies heart failure in a pediatric restrictive cardiomyopathy case, expediting life-saving treatment.
Why the study?
There is a paucity of literature on point-of-care ultrasound for the diagnosis of pediatric restrictive cardiomyopathy.
Case Report (n=1)
Point-of-care ultrasound can rapidly identify heart failure in pediatric patients with rare conditions like restrictive cardiomyopathy, expediting critical treatment.
Answers are grounded in this paper and cite their sources.
Supports POCUS for expedited pediatric HF diagnosis; leaves open prospective validation before practice change.
Restrictive cardiomyopathy is a rare form of cardiomyopathy in children, representing only 2.5%-3% of all pediatric cardiomyopathies, and is typically diagnosed between the ages of 6 and 10. The underlying etiology varies depending on age and region; however, idiopathic, genetic, and endomyocardial fibrosis are among the most common. Cohort studies have demonstrated mortality as high as 50% within 2 years of diagnosis, as well as high rates of adverse events including thromboembolism, pulmonary hypertension, and sudden cardiac death. There is a paucity of literature on point-of-care ultrasound (POCUS) for the diagnosis of pediatric restrictive cardiomyopathy. We present a case of a 3-year-old female whose diagnosis of heart failure was rapidly identified via POCUS which subsequently expedited life-saving treatment.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2025) conducted a case report in Restrictive cardiomyopathy (n=1). Point-of-care ultrasound (POCUS) was evaluated. Point-of-care ultrasound rapidly identified heart failure in a 3-year-old female with restrictive cardiomyopathy, expediting life-saving treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: